CLDX
Price
$21.26
Change
+$0.91 (+4.47%)
Updated
Jun 13 closing price
Capitalization
1.41B
54 days until earnings call
COGT
Price
$7.08
Change
-$0.14 (-1.94%)
Updated
Jun 13 closing price
Capitalization
806.1M
59 days until earnings call
Interact to see
Advertisement

CLDX vs COGT

Header iconCLDX vs COGT Comparison
Open Charts CLDX vs COGTBanner chart's image
Celldex Therapeutics
Price$21.26
Change+$0.91 (+4.47%)
Volume$2.82M
Capitalization1.41B
Cogent Biosciences
Price$7.08
Change-$0.14 (-1.94%)
Volume$1.51M
Capitalization806.1M
CLDX vs COGT Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. COGT commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and COGT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (CLDX: $21.26 vs. COGT: $7.08)
Brand notoriety: CLDX and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 303% vs. COGT: 101%
Market capitalization -- CLDX: $1.41B vs. COGT: $806.1M
CLDX [@Biotechnology] is valued at $1.41B. COGT’s [@Biotechnology] market capitalization is $806.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while COGT’s TA Score has 5 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 3 bearish.
  • COGT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than COGT.

Price Growth

CLDX (@Biotechnology) experienced а -0.42% price change this week, while COGT (@Biotechnology) price change was +4.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

COGT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.41B) has a higher market cap than COGT($806M). COGT YTD gains are higher at: -9.231 vs. CLDX (-15.869). CLDX has higher annual earnings (EBITDA): -213.94M vs. COGT (-284.04M). CLDX has more cash in the bank: 673M vs. COGT (246M). CLDX has less debt than COGT: CLDX (3.43M) vs COGT (17.1M). CLDX has higher revenues than COGT: CLDX (7.56M) vs COGT (0).
CLDXCOGTCLDX / COGT
Capitalization1.41B806M175%
EBITDA-213.94M-284.04M75%
Gain YTD-15.869-9.231172%
P/E RatioN/AN/A-
Revenue7.56M0-
Total Cash673M246M274%
Total Debt3.43M17.1M20%
FUNDAMENTALS RATINGS
CLDX vs COGT: Fundamental Ratings
CLDX
COGT
OUTLOOK RATING
1..100
6119
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
6469
SMR RATING
1..100
9296
PRICE GROWTH RATING
1..100
6243
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (57) in the Biotechnology industry is in the same range as COGT (82) in the Miscellaneous industry. This means that CLDX’s stock grew similarly to COGT’s over the last 12 months.

CLDX's Profit vs Risk Rating (64) in the Biotechnology industry is in the same range as COGT (69) in the Miscellaneous industry. This means that CLDX’s stock grew similarly to COGT’s over the last 12 months.

CLDX's SMR Rating (92) in the Biotechnology industry is in the same range as COGT (96) in the Miscellaneous industry. This means that CLDX’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (43) in the Miscellaneous industry is in the same range as CLDX (62) in the Biotechnology industry. This means that COGT’s stock grew similarly to CLDX’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as CLDX (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXCOGT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 27 days ago
82%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MBCNX16.18N/A
N/A
MassMutual Blue Chip Growth R3
VGREX6.98N/A
N/A
VALIC Company I Global Real Estate
RGSAX34.86N/A
N/A
Virtus KAR Global Small-Cap A
JGERX12.64N/A
N/A
JHancock Global Equity R2
SSSWX453.51N/A
N/A
State Street Equity 500 Index I

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+4.47%
BEAM - CLDX
53%
Loosely correlated
-2.18%
COGT - CLDX
51%
Loosely correlated
-1.94%
RVMD - CLDX
50%
Loosely correlated
-1.26%
DNLI - CLDX
49%
Loosely correlated
-2.51%
CRNX - CLDX
48%
Loosely correlated
-1.24%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.94%
SPHDF - COGT
63%
Loosely correlated
N/A
XNCR - COGT
56%
Loosely correlated
-2.55%
IDYA - COGT
55%
Loosely correlated
-0.45%
ATXS - COGT
53%
Loosely correlated
+2.14%
CGON - COGT
53%
Loosely correlated
-2.42%
More